Evidence map›Paper›PMID 25653560›Full record

ReviewInternational journal of women's health2015

Non-invasive prenatal testing: a review of international implementation and challenges.

Megan Allyse, Mollie A Minear, Elisa Berson, Shilpa Sridhar, Margaret Rote, Anthony Hung, Subhashini Chandrasekharan

Open access · goldAbstract readReview
In one paragraph

Review in International journal of women's health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 117 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 6 pooled it
73.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 6 syntheses or guidelines pooled it, 350 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2019
    Pooled it
  5. Pooled it
  6. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2018
    Pooled it
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Non-Invasive Prenatal Testing (NIPT): A Paradigm Shift in Prenatal Care.International journal of preventive medicine · 2025
    Review
  19. Article
  20. Review

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Megan AllyseInstitute for Health and Aging, University of California San Francisco, San Francisco, California, USA.
Mollie A MinearDuke Science & Society, Duke University, Durham, NC, USA.
Elisa BersonTrinity College of Arts and Sciences, Duke University, Durham, NC, USA.
Shilpa SridharTrinity College of Arts and Sciences, Duke University, Durham, NC, USA.
Margaret RoteTrinity College of Arts and Sciences, Duke University, Durham, NC, USA.
Anthony HungTrinity College of Arts and Sciences, Duke University, Durham, NC, USA.
Subhashini ChandrasekharanDuke Global Health Institute, Duke University, Durham, NC, USA.
Duke University · USUniversity of California, San Francisco · US

Funding

The Management and Organization Core will be administered by the Center for GenomP50HG003391 · NHGRI · DUKE UNIVERSITY · PI BESKOW, LAURA M. · 2004 to 2014
$9.9M
Intellectual Property and Access to Noninvasive Prenatal Genetic TestingR01HG007074 · NHGRI · DUKE UNIVERSITY · PI CHANDRASEKHARAN, SUBHASHINI · 2013 to 2015
$1.1M
NHGRI NIH HHS P50 HG003391NHGRI NIH HHS R01 HG007074
6 · The paper itself

Abstract

Noninvasive prenatal genetic testing (NIPT) is an advance in the detection of fetal chromosomal aneuploidies that analyzes cell-free fetal DNA in the blood of a pregnant woman. Since its introduction to clinical practice in Hong Kong in 2011, NIPT has quickly spread across the globe. While many professional societies currently recommend that NIPT be used as a screening method, not a diagnostic test, its high sensitivity (true positive rate) and specificity (true negative rate) make it an attractive alternative to the serum screens and invasive tests currently in use. Professional societies also recommend that NIPT be accompanied by genetic counseling so that families can make informed reproductive choices. If NIPT becomes more widely adopted, States will have to implement regulation and oversight to ensure it fits into existing legal frameworks, with particular attention to returning fetal sex information in areas where sex-based abortions are prevalent. Although there are additional challenges for NIPT uptake in the developing world, including the lack of health care professionals and infrastructure, the use of NIPT in low-resource settings could potentially reduce the need for skilled clinicians who perform invasive testing. Future advances in NIPT technology promise to expand the range of conditions that can be detected, including single gene disorders. With these advances come questions of how to handle incidental findings and variants of unknown significance. Moving forward, it is essential that all stakeholders have a voice in crafting policies to ensure the ethical and equitable use of NIPT across the world.

Indexed as

chromosome aneuploidiesethicsgenetic testingglobalimplementationnoninvasive prenatal testing (NIPT)

Identifiers

PMID25653560
PMCPMC4303457
OpenAlexW2116869873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.